ClariVest Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.47K | Hold |
53
| – | – | ﹤0.01% | 561 |
|
|
2024
Q2 | $1.47K | Buy |
53
+12
| +29% | +$330 | ﹤0.01% | 561 |
|
|
2024
Q1 | $1.14K | Sell |
41
-17
| -29% | -$472 | ﹤0.01% | 644 |
|
|
2023
Q4 | $1.67K | Buy |
58
+42
| +263% | +$1.27K | ﹤0.01% | 581 |
|
|
2023
Q3 | $1K | Buy |
+16
| New | +$566 | ﹤0.01% | 690 |
|
|
2023
Q2 | – | Sell |
-123
| Closed | -$5K | – | 734 |
|
|
2023
Q1 | $5K | Sell |
123
-350
| -74% | -$15.1K | ﹤0.01% | 495 |
|
|
2022
Q4 | $25K | Sell |
473
-363,820
| -100% | -$17.4M | ﹤0.01% | 438 |
|
|
2022
Q3 | $15.9M | Sell |
364,293
-17,800
| -5% | -$865K | 0.77% | 27 |
|
|
2022
Q2 | $20M | Sell |
382,093
-16,273
| -4% | -$829K | 0.87% | 23 |
|
|
2022
Q1 | $20.6M | Buy |
398,366
+398,290
| +524,066% | +$20.7M | 0.81% | 27 |
|
|
2021
Q4 | $4K | Buy |
+76
| New | +$3.77K | ﹤0.01% | 591 |
|
|
2019
Q3 | – | Sell |
-8,849
| Closed | -$364K | – | 729 |
|
|
2019
Q2 | $364K | Sell |
8,849
-328
| -4% | -$13K | 0.01% | 391 |
|
|
2019
Q1 | $371K | Buy |
9,177
+6,421
| +233% | +$257K | 0.01% | 479 |
|
|
2018
Q4 | $115K | Buy |
2,756
+2,488
| +928% | +$103K | ﹤0.01% | 605 |
|
|
2018
Q3 | $11K | Hold |
268
| – | – | ﹤0.01% | 652 |
|
|
2018
Q2 | $9K | Hold |
268
| – | – | ﹤0.01% | 648 |
|
|
2018
Q1 | $9K | Buy |
268
+66
| +33% | +$2.27K | ﹤0.01% | 656 |
|
|
2017
Q4 | $7K | Sell |
202
-2
| -1% | -$68 | ﹤0.01% | 635 |
|
|
2017
Q3 | $7K | Buy |
204
+170
| +500% | +$5.46K | ﹤0.01% | 551 |
|
|
2017
Q2 | $1K | Sell |
34
-6,029
| -99% | -$190K | ﹤0.01% | 628 |
|
|
2017
Q1 | $197K | Sell |
6,063
-168
| -3% | -$5.3K | ﹤0.01% | 490 |
|
|
2016
Q4 | $192K | Sell |
6,231
-4,564
| -42% | -$139K | 0.01% | 493 |
|
|
2016
Q3 | $347K | Hold |
10,795
| – | – | 0.01% | 429 |
|
|
2016
Q2 | $360K | Buy |
10,795
+2,321
| +27% | +$74.1K | 0.01% | 401 |
|
|
2016
Q1 | $238K | Sell |
8,474
-8,735
| -51% | -$250K | 0.01% | 449 |
|
|
2015
Q4 | $527K | Buy |
17,209
+1,273
| +8% | +$40K | 0.01% | 344 |
|
|
2015
Q3 | $475K | Buy |
15,936
+15,723
| +7,382% | +$504K | 0.01% | 334 |
|
|
2015
Q2 | $7K | Hold |
213
| – | – | ﹤0.01% | 497 |
|
|
2015
Q1 | $7K | Sell |
213
-8,963
| -98% | -$285K | ﹤0.01% | 499 |
|
|
2014
Q4 | $270K | Buy |
9,176
+14
| +0.2% | +$401 | 0.01% | 312 |
|
|
2014
Q3 | $257K | Sell |
9,162
-31
| -0.3% | -$870 | 0.01% | 338 |
|
|
2014
Q2 | $260K | Hold |
9,193
| – | – | 0.01% | 340 |
|
|
2014
Q1 | $280K | Buy |
9,193
+50
| +0.5% | +$1.49K | 0.01% | 324 |
|
|
2013
Q4 | $266K | Sell |
9,143
-16,834
| -65% | -$490K | 0.01% | 333 |
|
|
2013
Q3 | $707K | Sell |
25,977
-54
| -0.2% | -$1.47K | 0.03% | 240 |
|
|
2013
Q2 | $692K | Buy |
+26,031
| New | +$719K | 0.03% | 223 |
|
Other funds holding PFE
ClariVest Asset Management's PFE Position: Q3 2024 in Review
ClariVest Asset Management held its Pfizer (PFE) position steady in Q3 2024 at 53 shares worth $1.47K. The position accounts for ﹤0.01% of the portfolio, ranked #561.
ClariVest Asset Management first reported a position in PFE in Q2 2013 and has held it in 36 quarters since. The position peaked at $20.6M in Q1 2022. 2,910 funds tracked by Wall St. Rank hold PFE as of Q3 2024.
- ClariVest Asset Management held 53 shares of Pfizer worth $1.47K as of Q3 2024.
- ClariVest Asset Management left its Pfizer share count unchanged in Q3 2024.
- Pfizer made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #561 holding.
- ClariVest Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 36 quarters since.
- ClariVest Asset Management's Pfizer position peaked at $20.6M in Q1 2022.
- 2,910 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.
Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.